Abstract
Background Patient referral to a transplant facility, a prerequisite for dialysis-treated patients to access kidney transplantation in Canada, is a subjective process that is not recorded in national dialysis or transplant registries. Patients who may benefit from transplant may not be referred. Methods In this observational study, we prospectively identified referrals for kidney transplant in adult patients between June 2010 and May 2013 in 12 transplant centers, and linked these data to information on incident dialysis patients in a national registry. Results Among 13,184 patients initiating chronic dialysis, the cumulative incidence of referral for transplant was 17.3%, 24.0%, and 26.8% at 1, 2, and 3 years after dialysis initiation, respectively; the rate of transplant referral was 15.8 per 100 patient-years (95% confidence interval, 15.1 to 16.4). Transplant referral varied more than three-fold between provinces, but it was not associated with the rate of deceased organ donation or median waiting time for transplant in individual provinces. In a multivariable model, factors associated with a lower likelihood of referral included older patient age, female sex, diabetes-related ESKD, higher comorbid disease burden, longer durations (>12.0 months) of predialysis care, and receiving dialysis at a location >100 km from a transplant center. Median household income and non-Caucasian race were not associated with a lower likelihood of referral. Conclusions Referral rates for transplantation varied widely between Canadian provinces but were not lower among patients of non-Caucasian race or with lower socioeconomic status. Standardization of transplantation referral practices and ongoing national reporting of referral may decrease disparities in patient access to kidney transplant.
Original language | English |
---|---|
Pages (from-to) | 1708-1721 |
Number of pages | 14 |
Journal | Journal of the American Society of Nephrology : JASN |
Volume | 30 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2019 |
Bibliographical note
Funding Information:Dr. Gill reports grants from Astellas, personal fees from Astellas, and personal fees from Sanofi, outside the submitted work. Dr. Kim reports grants from Astellas Pharma Canada, and grants from Pfizer Canada, outside the submitted work. Dr. Knoll reports grants from Astellas Canada, outside the submitted work. All of the remaining authors have nothing to disclose.
Funding Information:
Dr. Gill and Dr. Knoll are funded by Foundation Awards from the Canadian Institutes of Health Research. Data collection at the transplant centers was supported by an unrestricted grant from Roche Canada.
Publisher Copyright:
© 2019 by the American Society of Nephrology.
ASJC Scopus Subject Areas
- Nephrology
PubMed: MeSH publication types
- Journal Article
- Observational Study
- Research Support, Non-U.S. Gov't